RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $16,628 | -33.5% | 1,113 | -2.2% | 0.00% | – |
Q3 2022 | $25,000 | +31.6% | 1,138 | 0.0% | 0.00% | – |
Q2 2022 | $19,000 | -97.0% | 1,138 | -94.6% | 0.00% | -100.0% |
Q1 2022 | $625,000 | +7.2% | 20,884 | +10.0% | 0.00% | 0.0% |
Q4 2021 | $583,000 | – | 18,988 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |